Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR-TKIs Resistance

被引：0

作者：

Tian, Jin ^{[1
]}

Shi, Zhiqi ^{[2
]}

Zhao, Lili ^{[1
]}

Liu, Peng ^{[1
]}

Sun, Xiaojun ^{[1
]}

Long, Lin ^{[1
]}

Zang, Jianhua ^{[1
]}

Xiao, Jun ^{[1
]}

机构：

[1] Qingdao Univ, Qingdao Hiser Hosp, Qingdao Tradit Chinese Med Hosp, Qingdao, Shandong, Peoples R China

[2] Shandong Univ Tradit Chinese Med, Clin Coll 1, Jinan, Shandong, Peoples R China

来源：

CLINICAL RESPIRATORY JOURNAL | 2024年 / 18卷 / 12期

关键词：

EGFR-TKIs resistance; epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI); immune checkpoint inhibitors; immunotherapy; non-small cell lung cancer (NSCLC); CELL LUNG-CANCER; T-CELL; BLOCKADE; SENSITIVITY; MECHANISMS; MUTATIONS; DOCETAXEL; NIVOLUMAB; EFFICACY; THERAPY;

D O I：

10.1111/crj.70037

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the standard treatment choice for advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations. EGFR-TKIs have made significant progress in the treatment of advanced NSCLC patients, but drug resistance issues still inevitably arise. The mechanism of drug resistance and subsequent treatment has been current research challenge and priority. Immune checkpoint inhibitors (ICIs) are a new choice for late-stage NSCLC patients without druggable molecular alterations. Currently, several studies have applied ICIs therapy for NSCLC patients with EGFR-TKIs resistance and explored the potential efficacy of ICIs. This review elaborates on the current status of immunotherapy after EGFR-TKIs resistance, including ICIs monotherapy, combined with EGFR-TKIs, chemotherapy, antiangiogenic drugs, and other therapies.

引用

页数：8

共 45 条

[1] Osimertinib Plus Durvalumab in Patients With EGFR-Mutated, Advanced NSCLC: A Phase 1b, Open-Label, Multicenter Trial [J].

Ahn, Myung-Ju ;

Cho, Byoung Chul ;

Ou, Xiaoling ;

Walding, Andrew ;

Dymond, Angela W. ;

Ren, Song ;

Cantarini, Mireille ;

Janne, Pasi A. .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (05) :718-723

[2] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[3] Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer [J].

Bracci, L. ;

Schiavoni, G. ;

Sistigu, A. ;

Belardelli, F. .

CELL DEATH AND DIFFERENTIATION, 2014, 21 (01) :15-25

[4] Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic [J].

Chan, T. A. ;

Yarchoan, M. ;

Jaffee, E. ;

Swanton, C. ;

Quezada, S. A. ;

Stenzinger, A. ;

Peters, S. .

ANNALS OF ONCOLOGY, 2019, 30 (01) :44-56

[5] ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation [J].

Chen, Xiaozheng ;

Gao, Aiqin ;

Zhang, Fang ;

Yang, Zijiang ;

Wang, Shuyun ;

Fang, Yuying ;

Li, Juan ;

Wang, Jingnan ;

Shi, Wenjing ;

Wang, Linlin ;

Zheng, Yan ;

Sun, Yuping .

THERANOSTICS, 2021, 11 (07) :3392-3416

[6] Discovering dominant tumor immune archetypes in a pan-cancer census [J].

Combes, Alexis J. ;

Samad, Bushra ;

Tsui, Jessica ;

Chew, Nayvin W. ;

Yan, Peter ;

Reeder, Gabriella C. ;

Kushnoor, Divyashree ;

Shen, Alan ;

Davidson, Brittany ;

Barczak, Andrea J. ;

Adkisson, Michael ;

Edwards, Austin ;

Naser, Mohammad ;

Barry, Kevin C. ;

Courau, Tristan ;

Hammoudi, Taymour ;

Arguello, Rafael J. ;

Rao, Arjun Arkal ;

Olshen, Adam B. ;

Cai, Cathy ;

Zhan, Jenny ;

Davis, Katelyn C. ;

Kelley, Robin K. ;

Chapman, Jocelyn S. ;

Atreya, Chloe E. ;

Patel, Amar ;

Daud, Adil, I ;

Ha, Patrick ;

Diaz, Aaron A. ;

Kratz, Johannes R. ;

Collisson, Eric A. ;

Fragiadakis, Gabriela K. ;

Erle, David J. ;

Boissonnas, Alexandre ;

Asthana, Saurabh ;

Chan, Vincent ;

Krummel, Matthew F. .

CELL, 2022, 185 (01) :184-+

[7] KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway [J].

Du, Wenwen ;

Zhu, Jianjie ;

Zeng, Yuanyuan ;

Liu, Ting ;

Zhang, Yang ;

Cai, Tingting ;

Fu, Yulong ;

Zhang, Weijie ;

Zhang, Ruochen ;

Liu, Zeyi ;

Huang, Jian-an .

CELL DEATH AND DIFFERENTIATION, 2021, 28 (04) :1284-1300

[8] Non-Small Cell Lung Cancer, Version 3.2022 [J].

Ettinger, David S. ;

Wood, Douglas E. ;

Aisner, Dara L. ;

Akerley, Wallace ;

Bauman, Jessica R. ;

Bharat, Ankit ;

Bruno, Debora S. ;

Chang, Joe Y. ;

Chirieac, Lucian R. ;

D'Amico, Thomas A. ;

DeCamp, Malcolm ;

Dilling, Thomas J. ;

Dowell, Jonathan ;

Gettinger, Scott ;

Grotz, Travis E. ;

Gubens, Matthew A. ;

Hegde, Aparna ;

Lackner, Rudy P. ;

Lanuti, Michael ;

Lin, Jules ;

Loo, Billy W. ;

Lovly, Christine M. ;

Maldonado, Fabien ;

Massarelli, Erminia ;

Morgensztern, Daniel ;

Ng, Thomas ;

Otterson, Gregory A. ;

Pacheco, Jose M. ;

Patel, Sandip P. ;

Riely, Gregory J. ;

Riess, Jonathan ;

Schild, Steven E. ;

Shapiro, Theresa A. ;

Singh, Aditi P. ;

Stevenson, James ;

Tam, Alda ;

Tanvetyanon, Tawee ;

Yanagawa, Jane ;

Yang, Stephen C. ;

Yau, Edwin ;

Gregory, Kristina ;

Hughes, Miranda .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05) :497-530

[9] Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges [J].

Fukurnura, Dal ;

Kloepper, Jonas ;

Amoozgar, Zohreh ;

Duda, Dan G. ;

Jain, Rakesh K. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (05) :325-340

[10] EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis [J].

Gainor, Justin F. ;

Shaw, Alice T. ;

Sequist, Lecia V. ;

Fu, Xiujun ;

Azzoli, Christopher G. ;

Piotrowska, Zofia ;

Huynh, Tiffany G. ;

Zhao, Ling ;

Fulton, Linnea ;

Schultz, Katherine R. ;

Howe, Emily ;

Farago, Anna F. ;

Sullivan, Ryan J. ;

Stone, James R. ;

Digumarthy, Subba ;

Moran, Teresa ;

Hata, Aaron N. ;

Yagi, Yukako ;

Yeap, Beow Y. ;

Engelman, Jeffrey A. ;

Mino-Kenudson, Mari .

CLINICAL CANCER RESEARCH, 2016, 22 (18) :4585-4593

← 1 2 3 4 5 →